Cannara Biotech, Inc. · TSX:LOVE
Cannara Biotech — Q3 2025 Earnings Presentation
21 slides from Cannara Biotech's earnings presentation, July 2025
Slide 1: Premium-Grade Cannabis at Scale
TSXV: LOVE | OTCQB: LOVFF | FRA: 8CB0 PREMIUM-GRADE CANNABIS AT SCALE INVESTOR DECK Q3 FISCAL 2025 (AS OF MAY 31, 2025)
Slide 2: Disclaimer
General Disclaimer This presentation is qualified in its entirety by reference to, and must be read in conjunction with, the information contained in the Company’s most recent Annual Information Form, as well as in the Company’s most recent consolidated financial statements, together with the notes
Slide 3: Forward-Looking Statements
General Forward-Looking Statements This presentation may contain “forward-looking information” within the meaning of Canadian securities legislation (“forward-looking statements”). These forward-looking statements are made as of the date of this presentation and the Company does not intend, and does
Slide 4: An Emerging Leader In Canada
An Emerging Leader In Canada Vertically-integrated Licensed Producer of premium-grade cannabis products Canada’s 7th Top LP by sales1 Total owned potential production capacity of up to 100,000kg of annualized cultivation output: • Activated rooms 11 + 12 at Valleyfield, increasing originally planned
Slide 5: Profitability Sets Us Apart
Profitability Sets Us Apart For the quarter ended For the quarter ended % Change May 31, 2025 May,31 2024 $37.8M $26.2M 44% $27.3M $19.5M 40% $12.1M $5.7M 110% Overview 44% 29% 50% Performance $5.6M $4.8M 17% Assets Strategy $7.6M $2.8M 174% Leadership Summary 28% 14% 100% $4.1M $2.0M 105% $13.9M $4
Slide 6: Well Capitalized Balance Sheet
Well Capitalized Balance Sheet As at May 31, 2025 As at August 31, 2024 % Change $14.4M $6.6M 118% $49.4M $40.5M 22% Overview As at July 25, 2025 As at July 25, 2024 As at July 26, 2022 Performance 91.4M 90.0M 87.7M Assets Strategy Financial Milestones Leadership Summary • Repaid $1M against our $6M
Slide 7: Increasing Our Market Share
Increasing Our Market Share May 2025 – Highest Estimated Top-performing Products National Retail Sales $19.6M #1 Quebec’s #1 Infused pre-roll Estimated Retail Market Share #1 Canada’s #1 Premium Live Resin Vape Province June 2025 Q3 2025 Q2 2025 Q1 2025 Overview Performance QC 12.6% 12.3% 12.8% 12.5
Slide 8: Canadian Recreational Cannabis Market
Canadian Recreational Cannabis Market 2ND Largest Cannabis Market in the world Legal Cannabis Market expected to Monthly Retail Sales of Legal reach Cannabis Stores in Canada from ~$9.81 billion CDN (US$6.58 B) by 20291 October 2018 to June 20252 7 Retail sales in million CDN dollars Overview 6 500
Slide 9: Two Quebec Based Mega Facilities
Two Quebec Based Mega Facilities Completely automated equipped with cutting edge technologies Overview Performance Assets Strategy Leadership Each activated zone has been designed to replicate indoor growing conditions Summary eliminating variability and maximizing quality. Farnham Facility Valleyfi
Slide 10: Why Quebec
Why Quebec Average Electricity Rates By Province In Cents Per Kw Hour Quebec has the lowest electricity rates in Canada QC MB BC ON SK NS AB 5.9¢/kWh 6.0¢/kWh 7.4¢/kWh 10.3¢/kWh 11.1¢/kWh 11.6¢/kWh 14.1¢/kWh Overview Performance Assets Quebec has the highest barriers Strategy 784 503 112 174 of entr
Slide 11: Disciplined Growth & Expansion
Disciplined Growth & Expansion Cannara’s Estimated Fiscal Year End Production Capacity in kg 120,000 100,000 100,000 Annualized Production (kg) Overview 80,000 80,000 Performance Assets 65,000 Strategy 60,000 Leadership 50,000 50,000 Summary 40,000 30,500 33,500 Total owned potential production capa
Slide 12: Scaling Sales
Scaling Sales Cannabis Revenue Growth Trajectory as Valleyfield Production Scales Up Cannabis NET Revenue in $ Millions Gross Profit Before Fair Value Adjustment % Gross Margin 100% $27.3 $26.6 90% $24.0 Overview 80% $22.1 Performance 70% Assets $18.5 $18.8 $18.3 Strategy $17.2 60% Leadership $14.9
Slide 13: Competitive Advantage
Competitive Advantage Scalable Quality Innovation in Products & Genetics • Deliver true to craft like procedures including hang drying and • Diverse portfolio of products: dried flower, pre-rolls, hand trimming cannabis to ensure quality. infused pre-rolls, milled flower, vapes, edibles, hash and •
Slide 14: Delivering Premium Quality Cannabis
Delivering Premium Quality Cannabis Focusing on high cannabinoid content and rich flavourful cannabis Our cannabis is grown using Rare genetics Hang dried & slow cured methods inspired by the most sophisticated markets in the Overview world: Performance Assets Strategy Leadership Summary Quality Acc
Slide 15: Portfolio of Brands
Portfolio of Brands - Overview Performance Assets Strategy Leadership Summary Q3 FY2025 15
Slide 16: Cannara Strategy
Cannara Strategy Delivering a premium-quality product at scale and at lower prices for consumers is at the heart of our strategy Purposeful growth by focusing on the Canadian legal market that is expected to reach ~$9.81 billion CDN (US$6.58 B) by 20291 Overview Respond to market demand by increasin
Slide 17: Capitalization & Market Valuation
Capitalization & Market Valuation Current Capitalization Table Estimated Market Capitalization 91,433,135 625,000 $162.8M Overview Closing Share Price Performance 5,039,071 2,611,111 Assets $1.78 Strategy Leadership Summary 202,500 Term loan and Credit facility with >50% BMO supporting growth of Can
Slide 18: Executive Leadership Team
Executive Leadership Team Zohar is an entrepreneur who has Nicholas Sosiak, CPA, is the Avi has been in the information launched several successful businesses. dynamic and hands-on CFO technology industry for over 20 He has founded, advised and invested of Cannara Biotech, years. He specializes in i
Slide 19: Executive Leadership Team
Executive Leadership Team ZOHAR KRIVOROT MARY DUROCHER JUSTIN COHEN CHAIRMAN & CEO DIRECTOR DIRECTOR Zohar is a seasoned entrepreneur who Mary has been involved in the Justin Cohen is a seasoned executive has built and grown multiple successful cannabis industry since the specializing in scaling bus
Slide 20: In Summary: Positioned for National Success
In Summary Well capitalized, fast-growing business Operating with strong margins and with an established history of execution with a focus on positive EBITDA, cash flow and profitability Offering customers the highest value Overview products at disruptive low prices Performance State of the art Queb
Slide 21: Thank You
TSXV: LOVE | OTCQB: LOVFF | FRA: 8CB0 THANK YOU Overview Performance www.cannara.ca Assets Strategy investors.cannara.ca Leadership Summary www.instagram.com/cannarabiotech www.facebook.com/cannarabiotech CANNARA HEADQUARTERS FARNHAM FACILITY VALLEYFIELD FACILITY 333 Decarie Blvd., Suite 200 1144 Bo